Rodrigues, M. A.Marzano, I. M.Ribeiro, G. H.Colina-Vegas, L.Pivatto, M.Fontes, A. P.S.Ribeiro, C. M. [UNESP]Pavan, F. R. [UNESP]De Almeida, K. J.Batista, A. A.Pereira-Maia, E. C.Guerra, W.2022-04-292022-04-292015-07-02Polyhedron, v. 98, p. 146-153.0277-5387http://hdl.handle.net/11449/228000This work reports on the synthesis and characterization of complexes of the type cis-[Pt(L)<inf>2</inf>X<inf>2</inf>], where L = 4-methoxybenzylcarbazate (4-MC), benzyl carbazate (BC), 4-fluorophenoxyacetic acid hydrazide (4-FH), 3-methoxybenzoic acid hydrazide (3-MH), ethyl carbazate (EC), tert-butyl carbazate (TC), (4-hydroxy-phenyl)-acetic acid hydrazide (4-HH), and X = Cl^- or I^-. The structures of the platinum(II) complexes were optimized and theoretical data show good agreement with the experimental results, suggesting that the ligands are coordinated via the NH<inf>2</inf> groups. The cytotoxic activity of three representative compounds was evaluated in a chronic myelogenous leukemia cell line and health cell line from mouse (L929). The platinum complex with 4-fluorophenoxyacetic acid hydrazide was more active than the free ligand and carboplatin therefore it may be considered a promising antitumor agent. In addition, the platinum complexes with 4-methoxybenzylcarbazate (4-MC) and benzyl carbazate (BC) exhibited good activity. On the other hand, microbiological assays against Mycobacterium tuberculosis showed that all complexes and organic compounds are not very active.146-153engCarbazateComputational modelingCytotoxic activityHydrazidePlatinum complexesArtigo10.1016/j.poly.2015.06.0252-s2.0-84933520888